https://www.selleckchem.com/products/azd5582.html
BACKGROUND Low molecular weight heparins (LMWH) are often used as a first-line therapy for the prevention of thrombosis in cancer patients. Preclinical evidence from animal models suggests that LMWH may have antimetastatic properties. Clinical evidence of this effect is inconclusive. The objective of this systematic review is to evaluate the effect of LMWH on overall survival in patients with solid tumor malignancies. METHODS MEDLINE, Embase, and The Cochrane Central Register of Controlled trials were searched from inception to Novemb
Like
Comment
Share
